ICU Medical (NASDAQ:ICUI) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
ICU Medical missed estimated earnings by 26.34%, reporting an EPS of $1.37 versus an estimate of $1.86.
Revenue was up $239.33 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 8.18% drop in the share price the next day.
Here’s a look at ICU Medical’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.78 | 1.64 | 1.80 | 1.64 |
| EPS Actual | 1.82 | 1.82 | 2.07 | 1.88 |
| Revenue Estimate | 553.17M | 319.90M | 314.30M | 305.43M |
| Revenue Actual | 543.12M | 340.52M | 336.06M | 321.68M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
ICU Medical management provided guidance for FY 2022, expecting earnings between $6.2 and $6.8 per share.
To track all earnings releases for ICU Medical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
